Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,003 public trials 2,033 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

NCT00006890

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • St. Mary's/Duluth Clinic Health System Duluth, Minnesota, United States
  • Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
  • Lethbridge Cancer Clinic Lethbridge, Alberta, Canada
  • Burnaby Hospital Regional Cancer Centre Burnaby, British Columbia, Canada
View all 64 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Patients With Multiple Myeloma

NCT00002678

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • St. Mary's/Duluth Clinic Health System Duluth, Minnesota, United States
  • Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada
View all 37 locations
View Trial Details
Completed

Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation

NCT00031668

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +30 more
Locations
  • Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
  • Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada
View Trial Details
Completed

Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis

NCT01318902

Conditions
Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
Locations
  • Tufts Medical Center Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's Lymphoma

NCT00064116

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
  • The Moncton Hospital Moncton, New Brunswick, Canada
View all 25 locations
View Trial Details
Completed

Study of ACTR087 in Subjects With Relapsed or Refractory B-cell Lymphoma

NCT02776813

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Yale University New Haven, Connecticut, United States
  • Loyola University Chicago Maywood, Illinois, United States
  • Indiana Bone and Marrow Transplantation Indianapolis, Indiana, United States
View Trial Details
Completed

Analyses of Human Samples Collected in Clinical Trials

NCT00339664

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +22 more
Locations
  • Childrens National Medical Center Washington D.C., District of Columbia, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • University of Maryland, Baltimore Baltimore, Maryland, United States
View all 17 locations
View Trial Details
Completed

Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis

NCT01222260

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • Tufts Medical Center Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Mt. Sinai Medical Center New York, United States
View Trial Details

Related conditions